Key result
Evolut FX frame deformation during TAV-in-SAV prevents recapture and forces deployment in the abdominal aorta.
Why the study?
Self-expanding TAVI valves feature the ability to be recaptured before the point of no recapture, but rare failure to recapture during TAV-in-SAV can occur.
Case Report (n=1)
No
This case highlights a rare complication where a self-expanding valve could not be recaptured during a TAV-in-SAV procedure due to anatomical and mechanical factors, resulting in its deployment in the abdominal aorta.
Answers are grounded in this paper and cite their sources.
Alerts operators to potential Evolut FX recapture failure in TAV-in-SAV; hypothesis-generating for device-specific risks and technique refinements.
Objective: The self-expanding valves used in transcatheter aortic valve implantation (TAVI) feature the ability to be recaptured before reaching the point of no recapture. We report a rare case of TAVI for surgical aortic valve dysfunction in which a self-expanding Evolut FX valve (Medtronic, Minneapolis, MN, USA) could not be recaptured and was consequently deployed in the abdominal aorta. Case Presentation: The patient was an 84-year-old male with a history of 2 previous surgical aortic valve replacements. He underwent transcatheter aortic valve-in-surgical aortic valve (TAV-in-SAV) for dysfunction of a bioprosthetic valve (Mosaic 21 mm; Medtronic) implanted approximately 18 years prior. During the deployment of a self-expanding Evolut FX 23-mm valve, it became impossible to recapture the device during the third repositioning attempt. Despite attempts to recapture the valve and remove it from the body, it was ultimately deployed in the abdominal aorta. Fortunately, blood flow to major branches, such as the superior mesenteric artery, was preserved, and no obvious circulatory compromise was observed. Subsequently, the second valve was successfully deployed in the intended position. Conclusion: We experienced a valuable case of TAV-in-SAV where a self-expanding aortic valve became impossible to recapture and was deployed in the abdominal aorta. Multiple contributing factors were suspected, including issues with the coaxiality of the device and the Evolut valve, interference between the surgical bioprosthesis and the Evolut valve, and the frame deformation. To our knowledge, no similar cases have been reported, and we present this case for its clinically important implications.
No takes yet. Share an insight, caveat, or question.
Ogawa et al. (2026) conducted a case report in Severe aortic valve stenosis (dysfunction of surgical bioprosthesis) (n=1). TAV-in-SAV with Evolut FX valve was evaluated. In an 84-year-old male undergoing TAV-in-SAV, a self-expanding Evolut FX valve could not be recaptured due to frame deformation and interference, resulting in its deployment in the abdominal aorta.
Synapse has enriched 10 related papers. Consider them for comparative context: